Company profile

Evelo Biosciences

Clinical stage biotech company developing a new modality of oral biologics that act on cells in the small intestine.

Industry
Biotechnology Research
Employees
16
Headquarters
Cambridge, MA
Founded
2015
LinkedIn followers
9,027
Office locations
1

Evelo Biosciences company summary

Evelo Biosciences is a company in the Biotechnology Research industry, headquartered in Cambridge, MA, founded in 2015. On LinkedIn the company has around 16 employees and 9,027 followers.

What technology does Evelo Biosciences use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Evelo Biosciences

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer. Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases and EDP1908 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.

Where is Evelo Biosciences located?

Evelo Biosciences lists 1 location.

Cambridge, MA, USHQ
One Kendall Square, Building 600/700

Compare companies similar to Evelo Biosciences

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Evelo Biosciences
evelobio.com
Biotechnology Research162015Cambridge, MA
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Evelo Biosciences

What does Evelo Biosciences do?

Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on the small intestinal axis, SINTAX™, with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company’s first product candidates are pharmaceutical preparations of single strains of microbes selected for their potential to offer defined pharmacological properties. Evelo’s therapies have the potential to be effective, safe, and affordable medicines to improve the lives of people with inflammatory diseases and cancer. Evelo currently has four product candidates in development: EDP1815, EDP1867, and EDP2939 for the treatment of inflammatory diseases and EDP1908 for the treatment of cancer. Evelo is advancing additional product candidates in other disease areas.

How many employees does Evelo Biosciences have?

Evelo Biosciences has around 16 employees on LinkedIn.

Where is Evelo Biosciences headquartered?

Evelo Biosciences is headquartered in Cambridge, MA.

When was Evelo Biosciences founded?

Evelo Biosciences was founded in 2015.

Build a lead list from companies like Evelo Biosciences

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.